Medication Deferral List

DO NOT STOP taking medications prescribed by your doctor in order to donate blood.

Donating while taking these drugs could have a negative effect on your health or on the health of the recipient of your blood.

PLEASE TELL US IF YOU...

Are being treated with ANY of the following types of medications...	or have taken...	which is also called...	any time in the last...
Anti-platelet agents (usually taken to prevent stroke or heart attack)	Feldene	piroxicam	2 days
	Effient	prasugrel	3 days
	Brilinta	ticagrelor	7 days
	Plavix	clopidogrel	14 days
	Ticlid	ticlopidine
	Zontivity	vorapaxar	1 month
Anticoagulants or “blood thinners” (usually taken to prevent blood clots in the legs and lungs and to prevent strokes)	Arixtra	fondaparinux	2 days
	Eliquis	apixaban
	Fragmin	dalteparin
	Lovenox	enoxaparin
	Pradaxa	dabigatran
	Savaysa	edoxaban
	Xarelto	rivaroxaban
	Coumadin Warfilone Jantoven	warfarin	7 days
	Heparin, low molecular weight heparin
Acne treatment	Accutane Amnesteem Absorica Claravis Myorisan Sotret Zenatane	isotretinoin	1 Month
Multiple myeloma	Thalomid	thalidomide
	Revlimid	lenalidomine
Rheumatoid arthritis	Rinvoq	upadacitinib
Hair loss remedy	Propecia	finasteride
Prostate symptoms	Proscar	finasteride
	Avodart Jalyn	dutasteride	6 Months
Immunosuppressant	Cellcept	mycophenolate mofetil	6 weeks
Hepatitis exposure	Hepatitis B Immune Globulin	HBIG	3 months
HIV Prevention ( also known as PrEP and PEP)
Any medication taken by mouth (oral) to prevent HIV	Truvada	emtricitabine and tenofovir disoproxil fumarate	3 Months
	Descovy	emtricitabine and tenofovir alafenamide
Injectable HIV prevention	Apretude	cabotegravir	2 years
Basal cell skin cancer	Erivedge Odomzo	vismodegib sonidegib	2 years
Relapsing multiple sclerosis	Aubagio	teriflunomide
Rheumatoid arthritis	Arava	leflunomide
Psoriasis	Soriatane	acitretin	3 years
	Tegison	etretinate	Ever
HIV treatment	Any medication to treat HIV. May also be called antiretroviral therapy (ART)
Experimental Medication			12 months

DO NOT STOP taking medications prescribed by your doctor in order to donate blood.

Some medications may affect donor eligibility for the following reasons:

Anti-platelet agents affect platelet function, so people taking these drugs should not donate platelets for the indicated time. You may still be able to donate whole blood or red blood cells by apheresis.

Anticoagulants or "blood thinners" are used to treat or prevent blood clots in the legs, lungs, or other parts of the body, and to prevent strokes. These medications affect the blood’s ability to clot, which might cause excessive bruising or bleeding when you donate; You may still be able to donate whole blood or red blood cells by apheresis.

Isotretinoin, finasteride, dutasteride acitretin and etretinate can cause birth defects. Your donated blood could contain high enough levels to damage the unborn baby if transfused to a pregnant woman.

Thalomid (thalidomide), Revlimid (lenalidomide) Erivedge (Vismodegib), Odomzo (sonidegib), Aubagio (teriflunomide), and Rinvoq (upadacitinib) may cause birth defects or the death of an unborn baby if transfused to a pregnant woman.

Cellcept (mycophenolate mofetil) and Arava (leflunomide) are immunosuppressants that may cause birth defects or the death of an unborn baby if transfused to a pregnant woman.

PrEP or pre-exposure prophylaxis involves taking a specific combination of oral medicines (short-acting antiviral PrEP) or injections (long-acting antiviral PrEP) as a prevention method for people who are HIV negative and at high risk of HIV infection. FDA has determined that the available data demonstrate that the use of PrEP or PEP may delay the detection of HIV by currently licensed screening tests for blood donations, potentially resulting in false negative results in infected individuals. Although “Undetectable = Untransmittable” for sexual transmission, this does not apply to transfusion transmission.

PEP or post-exposure prophylaxis is a short-acting treatment started as soon as possible after a high-risk exposure to HIV to reduce the risk of infection. FDA has determined that the available data demonstrate that the use of PrEP or PEP may delay the detection of HIV by currently licensed screening tests for blood donations, potentially resulting in false negative results in infected individuals. Although “Undetectable = Untransmittable” for sexual transmission, this does not apply to transfusion transmission.

ART or antiretroviral therapy is the use of a combination of HIV medicines (called an HIV regimen) to treat HIV infection. HIV infection requires a permanent deferral despite treatment with ART. Antiretroviral drugs do not fully eliminate the virus from the body, and donated blood from individuals infected with HIV taking ART can potentially still transmit HIV to a transfusion recipient. Although “Undetectable = Untransmittable” for sexual transmission, this does not apply to transfusion transmission.

Hepatitis B Immune Globulin (HBIG) is an injected material used to prevent hepatitis B infection following a possible or known exposure to hepatitis B. HBIG does not prevent hepatitis B infection in every case, therefore, persons who have received HBIG must wait to donate blood.

Experimental Medications are usually associated with a research study, and the effect on their safety of transfused blood is unknown.

_{Legacy Doc No: 15.4.fs401 Rev#: 5}